This same group, years later, has demonstrated that CD123 is prominently displayed on NPM1-mutated AML cells at both initial diagnosis and relapse, with particularly elevated expression in cases harboring concurrent FLT3-ITD mutations. Here, NPM1 is linked to acute myeloid leukemia.